CorMedix (NASDAQ: CRMD) reported Q1 EPS of $0.32, $0.16 better than the analyst estimate of $0.16. Revenue for the quarter came in at $39.1 million versus the consensus estimate of $32.35 million.

For earnings history and earnings-related data on CorMedix (CRMD) click here.